MedTrace Logo

Patient-controlled Sedation in Port Implantation (PACSPI-1)

NCT04631393 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2021-10-19

No results posted yet for this study

Summary

The purpose of this prospective, observational study is to assess the feasibility of patient-controlled sedation (PCS) for implantation of subcutaneous venous ports (SVP).

Conditions

  • Pain
  • Patient Satisfaction

Interventions

DRUG

Propofol Alfentanil

Propofol and Alfentanil are self-administered by the participant.

Sponsors & Collaborators

  • Stefanie Seifert

    lead OTHER_GOV

Principal Investigators

  • Margaretha Stenmarker, MD, PhD · Region Jönköping County

Eligibility

Min Age
18 Years
Max Age
105 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-14
Primary Completion
2021-10-15
Completion
2021-10-15

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04631393 on ClinicalTrials.gov